世界の卵巣がん治療薬市場予測2021-2027:プラチナ抗がん剤、フルオロピリミジン、アントラシクリン抗生物質、治療用抗体、小分子薬、アロマターゼ阻害剤(標的療法薬)、抗エストロゲン、アロマターゼ阻害剤(内分泌療法薬)

Market Monitor Globalが発行した調査報告書(MMG21DC17806)
◆英語タイトル:Ovarian Cancer Treatment Drugs Market - Global Outlook and Forecast 2021-2027
◆商品コード:MMG21DC17806
◆発行会社(リサーチ会社):Market Monitor Global
◆発行日:2021年12月(※2024年版があります。お問い合わせください。)
◆ページ数:91
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥481,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥625,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarket Monitor Global社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。

Market Monitor Global社が発行した本調査レポートは、世界の卵巣がん治療薬市場について調査し取りまとめました。卵巣がん治療薬の世界市場規模(2016年-2027年)、市場予測、企業別市場シェア、種類別分析(プラチナ抗がん剤、フルオロピリミジン、アントラシクリン抗生物質、治療用抗体、小分子薬、アロマターゼ阻害剤(標的療法薬)、抗エストロゲン、アロマターゼ阻害剤(内分泌療法薬))、用途別分析(病院、クリニック、ドラッグストア、その他)、地域別分析(北米、アメリカ、カナダ、メキシコ、ヨーロッパ、ドイツ、フランス、イギリス、アジア、中国、日本、韓国、東南アジア、インド、南米、ブラジル、中東、アフリカなど)、関連メーカーの概要、市場動向・機会・成長・阻害要因、サプライチェーンなどの情報をお届けいたします。
・世界の卵巣がん治療薬市場規模2021年vs2027年
・世界の卵巣がん治療薬市場:売上予測2016年-2027年
・主要企業別の卵巣がん治療薬売上・市場シェア・価格
・卵巣がん治療薬の種類別市場規模:プラチナ抗がん剤、フルオロピリミジン、アントラシクリン抗生物質、治療用抗体、小分子薬、アロマターゼ阻害剤(標的療法薬)、抗エストロゲン、アロマターゼ阻害剤(内分泌療法薬)
・卵巣がん治療薬の用途別市場規模:病院、クリニック、ドラッグストア、その他
・地域別市場規模
・卵巣がん治療薬の北米市場:アメリカ市場、カナダ市場、メキシコ市場
・卵巣がん治療薬のヨーロッパ市場:ドイツ市場、フランス市場、イギリス市場など
・卵巣がん治療薬のアジア市場:中国市場、日本市場、韓国市場、東南アジア市場など
・卵巣がん治療薬の南米市場:ブラジル市場、アルゼンチン市場など
・卵巣がん治療薬の中東・アフリカ市場:トルコ市場、サウジアラビア市場、UAE市場など
・主要メーカー及びブランド概要:AstraZeneca、Roche、Tesaro、Clovis Oncology、Kazia Therapeutics、Polaris Pharma
・世界の卵巣がん治療薬の生産能力2016年-2027年
・市場動向・機会・成長・阻害要因分析
・卵巣がん治療薬のサプライチェーン分析
・調査の結論
【レポートの概要】

This report contains market size and forecasts of Ovarian Cancer Treatment Drugs in global, including the following market information:
Global Ovarian Cancer Treatment Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Ovarian Cancer Treatment Drugs Market Sales, 2016-2021, 2022-2027, (MT)
Global top five Ovarian Cancer Treatment Drugs companies in 2020 (%)
The global Ovarian Cancer Treatment Drugs market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ovarian Cancer Treatment Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ovarian Cancer Treatment Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (MT)
Global Ovarian Cancer Treatment Drugs Market Segment Percentages, By Type, 2020 (%)
Platinum Anticancer Drugs
Fluoropyrimidines
Anthracycline Antibiotics
Therapertic Antibody
Small Molecules Drug
Aromatase Inhibitors (Targeted Therapy Drug)
Anti-estrogens
Aromatase Inhibitors (Endocrine Therapy Drug)

Global Ovarian Cancer Treatment Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (MT)
Global Ovarian Cancer Treatment Drugs Market Segment Percentages, By Application, 2020 (%)
Hospital
Clinic
Drugstore
Others

Global Ovarian Cancer Treatment Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (MT)
Global Ovarian Cancer Treatment Drugs Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ovarian Cancer Treatment Drugs revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Ovarian Cancer Treatment Drugs revenues share in global market, 2020 (%)
Key companies Ovarian Cancer Treatment Drugs sales in global market, 2016-2021 (Estimated), (MT)
Key companies Ovarian Cancer Treatment Drugs sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Roche
Tesaro
Clovis Oncology
Kazia Therapeutics
Polaris Pharma

【レポートの目次】

1 Introduction to Research & Analysis Reports
1.1 Ovarian Cancer Treatment Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ovarian Cancer Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ovarian Cancer Treatment Drugs Overall Market Size
2.1 Global Ovarian Cancer Treatment Drugs Market Size: 2021 VS 2027
2.2 Global Ovarian Cancer Treatment Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Ovarian Cancer Treatment Drugs Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Ovarian Cancer Treatment Drugs Players in Global Market
3.2 Top Global Ovarian Cancer Treatment Drugs Companies Ranked by Revenue
3.3 Global Ovarian Cancer Treatment Drugs Revenue by Companies
3.4 Global Ovarian Cancer Treatment Drugs Sales by Companies
3.5 Global Ovarian Cancer Treatment Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Ovarian Cancer Treatment Drugs Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Ovarian Cancer Treatment Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Ovarian Cancer Treatment Drugs Players in Global Market
3.8.1 List of Global Tier 1 Ovarian Cancer Treatment Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Ovarian Cancer Treatment Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Ovarian Cancer Treatment Drugs Market Size Markets, 2021 & 2027
4.1.2 Platinum Anticancer Drugs
4.1.3 Fluoropyrimidines
4.1.4 Anthracycline Antibiotics
4.1.5 Therapertic Antibody
4.1.6 Small Molecules Drug
4.1.7 Aromatase Inhibitors (Targeted Therapy Drug)
4.1.8 Anti-estrogens
4.1.9 Aromatase Inhibitors (Endocrine Therapy Drug)
4.2 By Type – Global Ovarian Cancer Treatment Drugs Revenue & Forecasts
4.2.1 By Type – Global Ovarian Cancer Treatment Drugs Revenue, 2016-2021
4.2.2 By Type – Global Ovarian Cancer Treatment Drugs Revenue, 2022-2027
4.2.3 By Type – Global Ovarian Cancer Treatment Drugs Revenue Market Share, 2016-2027
4.3 By Type – Global Ovarian Cancer Treatment Drugs Sales & Forecasts
4.3.1 By Type – Global Ovarian Cancer Treatment Drugs Sales, 2016-2021
4.3.2 By Type – Global Ovarian Cancer Treatment Drugs Sales, 2022-2027
4.3.3 By Type – Global Ovarian Cancer Treatment Drugs Sales Market Share, 2016-2027
4.4 By Type – Global Ovarian Cancer Treatment Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Ovarian Cancer Treatment Drugs Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Drugstore
5.1.5 Others
5.2 By Application – Global Ovarian Cancer Treatment Drugs Revenue & Forecasts
5.2.1 By Application – Global Ovarian Cancer Treatment Drugs Revenue, 2016-2021
5.2.2 By Application – Global Ovarian Cancer Treatment Drugs Revenue, 2022-2027
5.2.3 By Application – Global Ovarian Cancer Treatment Drugs Revenue Market Share, 2016-2027
5.3 By Application – Global Ovarian Cancer Treatment Drugs Sales & Forecasts
5.3.1 By Application – Global Ovarian Cancer Treatment Drugs Sales, 2016-2021
5.3.2 By Application – Global Ovarian Cancer Treatment Drugs Sales, 2022-2027
5.3.3 By Application – Global Ovarian Cancer Treatment Drugs Sales Market Share, 2016-2027
5.4 By Application – Global Ovarian Cancer Treatment Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region – Global Ovarian Cancer Treatment Drugs Market Size, 2021 & 2027
6.2 By Region – Global Ovarian Cancer Treatment Drugs Revenue & Forecasts
6.2.1 By Region – Global Ovarian Cancer Treatment Drugs Revenue, 2016-2021
6.2.2 By Region – Global Ovarian Cancer Treatment Drugs Revenue, 2022-2027
6.2.3 By Region – Global Ovarian Cancer Treatment Drugs Revenue Market Share, 2016-2027
6.3 By Region – Global Ovarian Cancer Treatment Drugs Sales & Forecasts
6.3.1 By Region – Global Ovarian Cancer Treatment Drugs Sales, 2016-2021
6.3.2 By Region – Global Ovarian Cancer Treatment Drugs Sales, 2022-2027
6.3.3 By Region – Global Ovarian Cancer Treatment Drugs Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country – North America Ovarian Cancer Treatment Drugs Revenue, 2016-2027
6.4.2 By Country – North America Ovarian Cancer Treatment Drugs Sales, 2016-2027
6.4.3 US Ovarian Cancer Treatment Drugs Market Size, 2016-2027
6.4.4 Canada Ovarian Cancer Treatment Drugs Market Size, 2016-2027
6.4.5 Mexico Ovarian Cancer Treatment Drugs Market Size, 2016-2027
6.5 Europe
6.5.1 By Country – Europe Ovarian Cancer Treatment Drugs Revenue, 2016-2027
6.5.2 By Country – Europe Ovarian Cancer Treatment Drugs Sales, 2016-2027
6.5.3 Germany Ovarian Cancer Treatment Drugs Market Size, 2016-2027
6.5.4 France Ovarian Cancer Treatment Drugs Market Size, 2016-2027
6.5.5 U.K. Ovarian Cancer Treatment Drugs Market Size, 2016-2027
6.5.6 Italy Ovarian Cancer Treatment Drugs Market Size, 2016-2027
6.5.7 Russia Ovarian Cancer Treatment Drugs Market Size, 2016-2027
6.5.8 Nordic Countries Ovarian Cancer Treatment Drugs Market Size, 2016-2027
6.5.9 Benelux Ovarian Cancer Treatment Drugs Market Size, 2016-2027
6.6 Asia
6.6.1 By Region – Asia Ovarian Cancer Treatment Drugs Revenue, 2016-2027
6.6.2 By Region – Asia Ovarian Cancer Treatment Drugs Sales, 2016-2027
6.6.3 China Ovarian Cancer Treatment Drugs Market Size, 2016-2027
6.6.4 Japan Ovarian Cancer Treatment Drugs Market Size, 2016-2027
6.6.5 South Korea Ovarian Cancer Treatment Drugs Market Size, 2016-2027
6.6.6 Southeast Asia Ovarian Cancer Treatment Drugs Market Size, 2016-2027
6.6.7 India Ovarian Cancer Treatment Drugs Market Size, 2016-2027
6.7 South America
6.7.1 By Country – South America Ovarian Cancer Treatment Drugs Revenue, 2016-2027
6.7.2 By Country – South America Ovarian Cancer Treatment Drugs Sales, 2016-2027
6.7.3 Brazil Ovarian Cancer Treatment Drugs Market Size, 2016-2027
6.7.4 Argentina Ovarian Cancer Treatment Drugs Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Ovarian Cancer Treatment Drugs Revenue, 2016-2027
6.8.2 By Country – Middle East & Africa Ovarian Cancer Treatment Drugs Sales, 2016-2027
6.8.3 Turkey Ovarian Cancer Treatment Drugs Market Size, 2016-2027
6.8.4 Israel Ovarian Cancer Treatment Drugs Market Size, 2016-2027
6.8.5 Saudi Arabia Ovarian Cancer Treatment Drugs Market Size, 2016-2027
6.8.6 UAE Ovarian Cancer Treatment Drugs Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Corporate Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Ovarian Cancer Treatment Drugs Major Product Offerings
7.1.4 AstraZeneca Ovarian Cancer Treatment Drugs Sales and Revenue in Global (2016-2021)
7.1.5 AstraZeneca Key News
7.2 Roche
7.2.1 Roche Corporate Summary
7.2.2 Roche Business Overview
7.2.3 Roche Ovarian Cancer Treatment Drugs Major Product Offerings
7.2.4 Roche Ovarian Cancer Treatment Drugs Sales and Revenue in Global (2016-2021)
7.2.5 Roche Key News
7.3 Tesaro
7.3.1 Tesaro Corporate Summary
7.3.2 Tesaro Business Overview
7.3.3 Tesaro Ovarian Cancer Treatment Drugs Major Product Offerings
7.3.4 Tesaro Ovarian Cancer Treatment Drugs Sales and Revenue in Global (2016-2021)
7.3.5 Tesaro Key News
7.4 Clovis Oncology
7.4.1 Clovis Oncology Corporate Summary
7.4.2 Clovis Oncology Business Overview
7.4.3 Clovis Oncology Ovarian Cancer Treatment Drugs Major Product Offerings
7.4.4 Clovis Oncology Ovarian Cancer Treatment Drugs Sales and Revenue in Global (2016-2021)
7.4.5 Clovis Oncology Key News
7.5 Kazia Therapeutics
7.5.1 Kazia Therapeutics Corporate Summary
7.5.2 Kazia Therapeutics Business Overview
7.5.3 Kazia Therapeutics Ovarian Cancer Treatment Drugs Major Product Offerings
7.5.4 Kazia Therapeutics Ovarian Cancer Treatment Drugs Sales and Revenue in Global (2016-2021)
7.5.5 Kazia Therapeutics Key News
7.6 Polaris Pharma
7.6.1 Polaris Pharma Corporate Summary
7.6.2 Polaris Pharma Business Overview
7.6.3 Polaris Pharma Ovarian Cancer Treatment Drugs Major Product Offerings
7.6.4 Polaris Pharma Ovarian Cancer Treatment Drugs Sales and Revenue in Global (2016-2021)
7.6.5 Polaris Pharma Key News
8 Global Ovarian Cancer Treatment Drugs Production Capacity, Analysis
8.1 Global Ovarian Cancer Treatment Drugs Production Capacity, 2016-2027
8.2 Ovarian Cancer Treatment Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Ovarian Cancer Treatment Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Ovarian Cancer Treatment Drugs Supply Chain Analysis
10.1 Ovarian Cancer Treatment Drugs Industry Value Chain
10.2 Ovarian Cancer Treatment Drugs Upstream Market
10.3 Ovarian Cancer Treatment Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Ovarian Cancer Treatment Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

...

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の卵巣がん治療薬市場予測2021-2027:プラチナ抗がん剤、フルオロピリミジン、アントラシクリン抗生物質、治療用抗体、小分子薬、アロマターゼ阻害剤(標的療法薬)、抗エストロゲン、アロマターゼ阻害剤(内分泌療法薬)(Ovarian Cancer Treatment Drugs Market - Global Outlook and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆